As the deletion of platelet-specific CD40L did not affect the size of atherosclerotic plaques or plaque phenotype, the ligand seems to be more involved in athero-thrombosis than atherosclerosis (Lacy et al., 2021). This evidence concerns the gene CD40LG and atherosclerosis.